Skip to main content
Fig. 3 | Acta Neuropathologica Communications

Fig. 3

From: Pyrroloquinoline quinone drives ATP synthesis in vitro and in vivo and provides retinal ganglion cell neuroprotection

Fig. 3

Effects of PQQ administration on ATP and NAD levels in visual system tissues in vivo. A ATP and B NAD content in retina, optic nerve, superior colliculus, and brain cortex from animals treated with either vehicle or a single injection of 20 mg/kg PQQ assessed after 24, 48 or 72 h from the treatment. n = 6 animals per group for each time point. *p < 0.05, **p < 0.01 and ***p < 0.001 versus vehicle

Back to article page